ePOSTER WALL Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View Poster Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View Poster Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis View Poster Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study View Poster Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab View Poster Epidemiology of COVID-19 in Patients with MS: A Hospital-Based Registry View Poster Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience) View Poster The Effect of Rituximab on Mood Disorders in Multiple Sclerosis View Poster Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab View Poster Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab View Poster Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait View Poster Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis View Poster Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab View Poster Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone View Poster Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS View Poster Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities View Poster Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets View Poster Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients View Poster Real-World Experience with Cladribine in the MSBase Registry View Poster Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis View Poster Neurofilament Light Chains: A Reliable Biomarker of Disease Activity in MS View Poster The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia View Poster Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut View Poster Lennox-Gastaut Syndrome and MS: Is it a Coincidence? View Poster NMOSD: How Long to Treat View Poster The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran. View Poster A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder View Poster Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population View Poster Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography View Poster Association of Multiple Sclerosis and COVID-19 Infection: A Case Report View Poster Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking? View Poster Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis View Poster Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History View Poster Sleep Disorders in Multiple Sclerosis Patients View Poster Anxiety in Patients with Multiple Sclerosis View Poster Depression in Multiple Sclerosis View Poster Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis View Poster Radiologically Isolated Syndrome Conversion to Multiple Sclerosis View Poster A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report View Poster Psychotic Symptoms Revealing Multiple Sclerosis: Case Report View Poster Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients View Poster Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis View Poster Adrenoleukodystrophy in Adults: About a Case View Poster MRI Findings in Late-Onset Multiple Sclerosis; a Systematic Review and Meta-Analysis View Poster Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients View Poster The Role of Gut Microbiata in Multiple Sclerosis View Poster COVID-19 in Multiple Sclerosis Patients in Dubai: Observational Study View Poster Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients View Poster Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study View Poster MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay View Poster The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID-19 Vaccine View Poster First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation View Poster Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis View Poster Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years View Poster Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study View Poster Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review View Poster Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center View Poster COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience View Poster Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East View Poster Challenges of MS Patients for Receiving Health Care Services View Poster Familial MS in the South Caspian Sea View Poster Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran. View Poster A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece View Poster Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia. View Poster Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region View Poster Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden View Poster Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco. View Poster Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience View Poster Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman View Poster Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS View Poster Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort View Poster The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia View Poster Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study View Poster
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View Poster
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View Poster
Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis View Poster
Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study View Poster
Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience) View Poster
Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab View Poster
Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait View Poster
Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis View Poster
Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab View Poster
Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone View Poster
Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS View Poster
Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients View Poster
Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis View Poster
Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut View Poster
The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran. View Poster
A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder View Poster
Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population View Poster
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography View Poster
Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis View Poster
Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History View Poster
A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report View Poster
Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients View Poster
Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients View Poster
Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study View Poster
MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay View Poster
The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID-19 Vaccine View Poster
Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study View Poster
Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review View Poster
Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East View Poster
Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran. View Poster
Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia. View Poster
Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region View Poster
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden View Poster
Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience View Poster
Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman View Poster
Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS View Poster
The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia View Poster
Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study View Poster
